Top Health Care companies in United States by Operating Income Margin

This ranking features the top 679 Health Care companies in United States ranked by Operating Income Margin, averaging a Operating Income Margin of -2,965,107.71%, for January 15, 2025.

United States

Health Care

#	Name	Operating Income Margin	Reported Date	Stock Price	Change	Country
1	Summit Therapeutics Inc. 1 SMMT	198,753.95%	Sept. 30, 2023	USD 16.65	-8.42%	United States
2	Tenax Therapeutics, Inc. 2 TENX	24,261.85%	Sept. 30, 2024	USD 6.43	4.38%	United States
3	Royalty Pharma plc 3 RPRX	68.14%	Sept. 30, 2024	USD 30.03	0.13%	United States
4	SIGA Technologies, Inc. 4 SIGA	60.19%	Sept. 30, 2024	USD 6.33	4.46%	United States
5	Halozyme Therapeutics, Inc. 5 HALO	50.35%	Sept. 30, 2024	USD 53.83	-0.57%	United States
6	United Therapeutics Corporation 6 UTHR	46.42%	Sept. 30, 2024	USD 364.70	0.50%	United States
7	Innoviva, Inc. 7 INVA	46.20%	Sept. 30, 2024	USD 17.68	0.68%	United States
8	Protagonist Therapeutics, Inc. 8 PTGX	46.05%	Sept. 30, 2024	USD 36.67	-1.26%	United States
9	Doximity, Inc. 9 DOCS	38.66%	Sept. 30, 2024	USD 50.77	2.13%	United States
10	Catalyst Pharmaceuticals, Inc. 10 CPRX	37.78%	Sept. 30, 2024	USD 22.19	-0.09%	United States
11	Global Medical REIT Inc. 11 GMRE	36.48%	Sept. 30, 2024	USD 7.82	0.51%	United States
12	Zoetis Inc. 12 ZTS	36.45%	Sept. 30, 2024	USD 164.41	-1.15%	United States
13	SWK Holdings Corporation 13 SWKH	35.61%	Sept. 30, 2024	USD 16.15	-0.92%	United States
14	Eli Lilly and Company 14 LLY	35.33%	Sept. 30, 2024	USD 744.91	-6.59%	United States
15	Semler Scientific, Inc. 15 SMLR	33.79%	Sept. 30, 2024	USD 54.93	4.23%	United States
16	Utah Medical Products, Inc. 16 UTMD	33.14%	Sept. 30, 2024	USD 61.49	0.77%	United States
17	Collegium Pharmaceutical, Inc. 17 COLL	32.29%	Sept. 30, 2024	USD 33.18	-1.80%	United States
18	Kiora Pharmaceuticals, Inc. 18 KPRX	31.84%	Sept. 30, 2024	USD 3.21	-5.87%	United States
19	Lantheus Holdings, Inc. 19 LNTH	31.68%	Sept. 30, 2024	USD 92.62	-2.15%	United States
20	Sotera Health Company 20 SHC	31.23%	Sept. 30, 2024	USD 12.76	-2.52%	United States
21	Mettler-Toledo International Inc. 21 MTD	30.03%	Sept. 30, 2024	USD 1.27 K	0.33%	United States
22	ADMA Biologics, Inc. 22 ADMA	30.01%	Sept. 30, 2024	USD 16.32	-1.03%	United States
23	IRadimed Corporation 23 IRMD	29.91%	Sept. 30, 2024	USD 57.52	1.79%	United States
24	Amphastar Pharmaceuticals, Inc. 24 AMPH	29.71%	Sept. 30, 2024	USD 38.48	1.48%	United States
25	Gilead Sciences, Inc. 25 GILD	29.63%	Sept. 30, 2024	USD 91.00	1.18%	United States
26	ResMed Inc. 26 RMD	29.50%	Sept. 30, 2024	USD 228.83	-0.62%	United States
27	Prestige Consumer Healthcare Inc. 27 PBH	29.30%	Sept. 30, 2024	USD 75.78	1.54%	United States
28	Regeneron Pharmaceuticals, Inc. 28 REGN	28.92%	Sept. 30, 2024	USD 690.87	-3.63%	United States
29	Sensus Healthcare, Inc. 29 SRTS	28.91%	Sept. 30, 2024	USD 6.64	4.08%	United States
30	Ironwood Pharmaceuticals, Inc. 30 IRWD	28.68%	Sept. 30, 2024	USD 3.65	-3.18%	United States
31	Edwards Lifesciences Corporation 31 EW	27.19%	Sept. 30, 2024	USD 71.04	-0.07%	United States
32	Entrada Therapeutics, Inc. 32 TRDA	26.85%	Sept. 30, 2024	USD 12.49	-6.58%	United States
33	Intuitive Surgical, Inc. 33 ISRG	26.24%	Sept. 30, 2024	USD 538.88	-0.16%	United States
34	Neurocrine Biosciences, Inc. 34 NBIX	26.19%	Sept. 30, 2024	USD 139.51	-2.46%	United States
35	Harmony Biosciences Holdings, Inc. 35 HRMY	25.71%	Sept. 30, 2024	USD 36.42	-0.08%	United States
36	AMETEK, Inc. 36 AME	25.40%	Sept. 30, 2024	USD 179.15	1.50%	United States
37	Illumina, Inc. 37 ILMN	25.26%	Sept. 29, 2024	USD 136.48	-5.37%	United States
38	Johnson & Johnson 38 JNJ	25.22%	Sept. 29, 2024	USD 144.75	0.19%	United States
39	Exelixis, Inc. 39 EXEL	25.16%	Sept. 27, 2024	USD 35.65	0.99%	United States
40	AbbVie Inc. 40 ABBV	24.89%	Sept. 30, 2024	USD 175.55	-0.67%	United States
41	Merck & Co., Inc. 41 MRK	23.52%	Sept. 30, 2024	USD 99.65	-1.32%	United States
42	Organon & Co. 42 OGN	23.44%	Sept. 30, 2024	USD 15.81	0.96%	United States
43	LeMaitre Vascular, Inc. 43 LMAT	23.26%	Sept. 30, 2024	USD 95.85	1.78%	United States
44	Hologic, Inc. 44 HOLX	23.21%	Sept. 28, 2024	USD 70.20	-0.13%	United States
45	Agilent Technologies, Inc. 45 A	23.10%	Oct. 31, 2024	USD 143.43	1.04%	United States
46	Corcept Therapeutics Incorporated 46 CORT	22.81%	Sept. 30, 2024	USD 51.66	1.18%	United States
47	MEI Pharma, Inc. 47 MEIP	22.27%	June 30, 2024	USD 2.75	1.10%	United States
48	MiMedx Group, Inc. 48 MDXG	21.81%	Sept. 30, 2024	USD 8.61	0.58%	United States
49	Bristol-Myers Squibb Company 49 BMY	21.74%	Sept. 30, 2024	USD 55.74	0.69%	United States
50	Biogen Inc. 50 BIIB	21.11%	Sept. 30, 2024	USD 143.06	-4.74%	United States

1 2 3 4 … 14

Frequently Asked Questions

Which Health Care company in United States has the highest Operating Income Margin ?

The Health Care company in United States with the highest Operating Income Margin is Summit Therapeutics Inc. (NasdaqGM: SMMT) at 198,753.95%.
Which Health Care company in United States has the lowest Operating Income Margin ?

The Health Care company in United States with the lowest Operating Income Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -2,006,394,100.00%.

What are the top 10 Health Care companies in United States by Operating Income Margin ?

The top 10 Health Care companies in United States by Operating Income Margin are Summit Therapeutics Inc., Tenax Therapeutics, Inc., Royalty Pharma plc, SIGA Technologies, Inc., Halozyme Therapeutics, Inc., United Therapeutics Corporation, Innoviva, Inc., Protagonist Therapeutics, Inc., Doximity, Inc. and Catalyst Pharmaceuticals, Inc..
What are the bottom 10 Health Care companies in United States by Operating Income Margin ?

The bottom 10 Health Care companies in United States by Operating Income Margin are Inhibikase Therapeutics, Inc., Allogene Therapeutics, Inc., Forte Biosciences, Inc., Immix Biopharma, Inc., Bullfrog AI Holdings, Inc. Common Stock, Benitec Biopharma Inc., Cadrenal Therapeutics, Inc. Common Stock, NRx Pharmaceuticals, Inc., Acelyrin, Inc. and Greenwich LifeSciences, Inc..